International Pharmaceutical Aerosol Consortium (IPAC)
represents leading manufacturers of metered dose inhalers. IPAC companies have been at the forefront of the reformulation of metered dose inhalers to replace CFC propellants with ozone friendly HFA alternatives such as ZEPHEX®134a and ZEPHEX®227ea.
International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS)
are an international association of innovator and generic companies that develop, manufacture or market orally inhaled and nasal drug products.